NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
/in Dendritic Cells, International Publications, Malignant LymphomaHSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer
/in Dendritic Cells, International PublicationsResistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
/in Checkpoint-Inhibitors, International PublicationsDendritic cell vaccination in melanoma patients: From promising results to future perspectives
/in Dendritic Cells, International Publications, Malignant MelanomaAnti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.
/in Breast Cancer, Dendritic Cells, International PublicationsIpilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
/in Dendritic Cells, International Publications, Malignant MelanomaThermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma
/in Hyperthermia, International Publications, NSCLCComparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells
/in Hyperthermia, International Publications, Malignant LymphomaProgress of dendritic cell-based cancer vaccines for patients with hematological malignancies
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer